Dimensional Fund Advisors’s Biostage, Inc. Common Stock BSTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-25,958
Closed -$47K 3310
2016
Q1
$47K Hold
25,958
﹤0.01% 3265
2015
Q4
$57K Sell
25,958
-248,763
-91% -$347K ﹤0.01% 3291
2015
Q3
$233K Sell
274,721
-31,281
-10% -$35.4K ﹤0.01% 3225
2015
Q2
$438K Sell
306,002
-13,607
-4% -$33.3K ﹤0.01% 3156
2015
Q1
$1.04M Sell
319,609
-37,620
-11% -$128K ﹤0.01% 2980
2014
Q4
$1.14M Sell
357,229
-10,630
-3% -$52.7K ﹤0.01% 2979
2014
Q3
$2.98M Sell
367,859
-3,747
-1% -$30.7K ﹤0.01% 2720
2014
Q2
$3.88M Sell
371,606
-4,465
-1% -$38K ﹤0.01% 2653
2014
Q1
$3.41M Sell
376,071
-250
-0.1% -$1.48K ﹤0.01% 2691
2013
Q4
$1.79M Buy
+376,321
New +$1.76M ﹤0.01% 2875

Other funds holding BSTG

Dimensional Fund Advisors's BSTG Position: Q2 2016 in Review

Dimensional Fund Advisors sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2016, closing a stake of 25,958 shares — an estimated $47K sold.

Dimensional Fund Advisors first reported a position in BSTG in Q4 2013 and held it in 10 quarters. The position peaked at $3.88M in Q2 2014. 29 funds tracked by Wall St. Rank hold BSTG as of Q2 2016.

  • Dimensional Fund Advisors reported no remaining Biostage, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Dimensional Fund Advisors sold 25,958 Biostage, Inc. Common Stock shares in Q2 2016, an estimated $47K.
  • Dimensional Fund Advisors first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 10 quarters.
  • Dimensional Fund Advisors's Biostage, Inc. Common Stock position peaked at $3.88M in Q2 2014.
  • 29 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2016.

Based on Dimensional Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.